Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stephen Hamilton-Dutoit
Pazopanib-Induced Liver Toxicity in Metastatic Renal Cell Carcinoma (mRCC) Patients: Impact of UGT1A1 Polymorphism on Pazopanib Dose Reduction, Safety and Patient Outcome
Clinical Genitourinary Cancer
Oncology
Urology
Comparative Analysis of Three- And Two-Antibody Cocktails to AMACR and Basal Cell Markers for the Immunohistochemical Diagnosis of Prostate Carcinoma
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
Related publications
Clinical Outcome of Third-Line Pazopanib in a Patient With Metastatic Renal Cell Carcinoma
Case Reports in Oncological Medicine
Oncology
Angiotensin Inhibitors as Treatment of Sunitinib/Pazopanib-Induced Hypertension in Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Pazopanib-Induced Alopecia, an Underestimated Toxicity?
Frontiers in Oncology
Cancer Research
Oncology
New Advancements and Developments in Treatment of Renal Cell Carcinoma: Focus on Pazopanib
OncoTargets and Therapy
Oncology
Pharmacology
Predictors of Long-Term Response With Pazopanib in Patients With Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?
Clinical Medicine Insights: Oncology
Oncology
Rationale for Targeted Therapies and Potential Role of Pazopanib in Advanced Renal Cell Carcinoma
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
